Latest Insider Transactions at Cigna Corp (CI)
This section provides a real-time view of insider transactions for Cigna Corp (CI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cigna Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cigna Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 24
2023
|
Eric P Palmer Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,564
-5.26%
|
$1,635,816
$294.27 P/Share
|
|
Feb 24
2023
|
Eric P Palmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,265
+17.42%
|
-
|
|
Feb 24
2023
|
Michael W Triplett Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
2,452
-3.51%
|
$720,888
$294.27 P/Share
|
|
Feb 24
2023
|
Michael W Triplett Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
5,633
+13.79%
|
-
|
|
Feb 24
2023
|
Cynthia Ryan EVP, CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
442
-2.87%
|
$129,948
$294.27 P/Share
|
|
Feb 24
2023
|
Cynthia Ryan EVP, CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
1,174
+13.16%
|
-
|
|
Feb 24
2023
|
Jason D Sadler Pres., International Health |
BUY
Grant, award, or other acquisition
|
Direct |
5,070
+9.73%
|
-
|
|
Feb 24
2023
|
Paul A Sanford EVP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
391
-1.82%
|
$114,954
$294.27 P/Share
|
|
Feb 24
2023
|
Paul A Sanford EVP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,040
+8.81%
|
-
|
|
Feb 24
2023
|
Noelle K Eder Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,007
-10.15%
|
$590,058
$294.27 P/Share
|
|
Feb 24
2023
|
Noelle K Eder Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,410
+21.48%
|
-
|
|
Feb 24
2023
|
Brian C Evanko Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,140
-4.42%
|
$923,160
$294.27 P/Share
|
|
Feb 24
2023
|
Brian C Evanko Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,759
+15.88%
|
-
|
|
Feb 24
2023
|
Nicole S Jones Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,155
-4.25%
|
$1,221,570
$294.27 P/Share
|
|
Feb 24
2023
|
Nicole S Jones Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,637
+14.92%
|
-
|
|
Feb 24
2023
|
David Cordani Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,707
-6.22%
|
$5,793,858
$294.27 P/Share
|
|
Feb 24
2023
|
David Cordani Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
37,549
+18.97%
|
-
|
|
Feb 24
2023
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
448
-2.18%
|
$131,712
$294.27 P/Share
|
|
Feb 24
2023
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,341
+11.5%
|
-
|
|
Feb 24
2023
|
Everett Neville EVP, Solutions & Corp Devt. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,911
-7.33%
|
$561,834
$294.27 P/Share
|
|
Feb 24
2023
|
Everett Neville EVP, Solutions & Corp Devt. |
BUY
Grant, award, or other acquisition
|
Direct |
4,694
+26.17%
|
-
|
|
Feb 22
2023
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
425
+4.52%
|
-
|
|
Feb 22
2023
|
David J Brailer EVP & Chief Health Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,395
+39.76%
|
-
|
|
Feb 22
2023
|
Noelle K Eder Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,855
+16.58%
|
-
|
|
Feb 22
2023
|
David Cordani Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,862
+8.13%
|
-
|
|
Feb 22
2023
|
Brian C Evanko Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,403
+13.16%
|
-
|
|
Feb 22
2023
|
Nicole S Jones Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,831
+6.52%
|
-
|
|
Feb 22
2023
|
Everett Neville EVP, Solutions & Corp Devt. |
BUY
Grant, award, or other acquisition
|
Direct |
1,783
+17.26%
|
-
|
|
Feb 22
2023
|
Cynthia Ryan EVP, CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
1,515
+18.73%
|
-
|
|
Feb 22
2023
|
Eric P Palmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,304
+11.18%
|
-
|
|
Feb 22
2023
|
Paul A Sanford EVP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
981
+9.16%
|
-
|
|
Feb 22
2023
|
Michael W Triplett Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
2,050
+6.48%
|
-
|
|
Feb 22
2023
|
Jason D Sadler Pres., International Health |
BUY
Grant, award, or other acquisition
|
Direct |
1,693
+3.88%
|
-
|
|
Feb 06
2023
|
Elder Granger Director |
SELL
Bona fide gift
|
Direct |
200
-4.27%
|
-
|
|
Jan 09
2023
|
David Cordani Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
50,700
+35.91%
|
-
|
|
Jan 09
2023
|
David Cordani Chairman & CEO |
SELL
Bona fide gift
|
Indirect |
50,700
-11.86%
|
-
|
|
Dec 19
2022
|
Cynthia Ryan EVP, CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
740
+12.76%
|
$102,860
$139.22 P/Share
|
|
Dec 16
2022
|
Cynthia Ryan EVP, CHRO |
SELL
Open market or private sale
|
Direct |
3,009
-41.06%
|
$983,943
$327.95 P/Share
|
|
Dec 16
2022
|
Cynthia Ryan EVP, CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,009
+29.11%
|
$418,251
$139.22 P/Share
|
|
Dec 09
2022
|
Jason D Sadler Pres., International Health |
BUY
Exercise of conversion of derivative security
|
Direct |
4,502
+5.44%
|
$855,380
$190.4 P/Share
|
|
Dec 08
2022
|
Jason D Sadler Pres., International Health |
SELL
Open market or private sale
|
Direct |
16,667
-17.31%
|
$5,566,778
$334.04 P/Share
|
|
Dec 08
2022
|
Jason D Sadler Pres., International Health |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+14.65%
|
$3,166,730
$190.4 P/Share
|
|
Nov 08
2022
|
William J De Laney Iii Director |
SELL
Bona fide gift
|
Direct |
2,452
-11.11%
|
-
|
|
Oct 14
2022
|
Paul A Sanford EVP Operations |
SELL
Open market or private sale
|
Direct |
373
-4.09%
|
$111,900
$300.0 P/Share
|
|
Oct 14
2022
|
Eric P Palmer Officer |
SELL
Open market or private sale
|
Direct |
4,000
-9.79%
|
$1,200,000
$300.0 P/Share
|
|
Sep 14
2022
|
Noelle K Eder Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
902
-7.27%
|
$257,070
$285.46 P/Share
|
|
Sep 13
2022
|
Michael W Triplett Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
2,449
+8.17%
|
$340,411
$139.22 P/Share
|
|
Sep 12
2022
|
Michael W Triplett Special Advisor |
SELL
Open market or private sale
|
Direct |
8,260
-24.77%
|
$2,411,920
$292.76 P/Share
|
|
Sep 12
2022
|
Michael W Triplett Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
6,060
+15.38%
|
$842,340
$139.22 P/Share
|
|
Sep 01
2022
|
David J Brailer EVP & Chief Health Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,749
+50.0%
|
-
|